AMN Healthcare Earnings Call: Surge Peaks, Risks Loom

AMN Healthcare ((AMN)) has held its Q1 earnings call. Read on for the main highlights of the call.

AMN Healthcare’s latest earnings call struck a cautiously upbeat tone, as management highlighted a sizable revenue beat, robust profitability, and strong cash generation, largely powered by an exceptional quarter for labor disruption work and rapid‑response deployments. Yet executives repeatedly warned that much of this outsized benefit is unlikely to recur, underscoring a mixed backdrop of improving core trends but mounting competitive and pricing pressures.

Revenue Beat Showcases Rapid Scale During Labor Disruptions

AMN reported first‑quarter revenue of $1.38 billion, surpassing guidance by $122 million and comfortably topping market expectations thanks to five major labor disruption events. Management emphasized the company’s ability to mobilize thousands of clinicians on short notice, underscoring AMN’s operational scale and positioning as a go‑to partner for hospitals facing urgent staffing crises.

Profitability Surges With Strong EBITDA and Cash Flow

Adjusted EBITDA climbed to $166 million, or 12.1% of revenue, beating the high end of guidance and marking a 280‑basis‑point margin expansion year over year and 480 bps sequentially. Net income swung to $62 million from a small loss a year earlier, while operating cash flow surged to $562 million against modest $7 million capital spending, yielding significant free cash generation.

Balance Sheet Strengthens as Leverage Falls

The company ended the quarter with $551 million in cash and equivalents and total debt of $750 million after paying down its revolving credit facility. On a credit‑agreement basis, leverage declined to 1.6x, and management expects to keep leverage at or below roughly 2x through year‑end, giving AMN added flexibility for investment and potential capital allocation.

Nurse & Allied Core Business Gains Momentum

Nurse & Allied Solutions revenue reached $1.13 billion, including $722 million from labor disruption work, highlighting the outsized role of event‑driven demand this quarter. Excluding that, segment revenue was $405 million, up 8% year over year and 11% sequentially, with travel nurse revenue growing about 12% and allied revenue up 3%, signaling healthier underlying demand trends.

Gross Margin Expansion Led by Mix and Event Work

Consolidated gross margin came in at 26.8%, above expectations and aided by the high‑margin nature of rapid‑response and disruption assignments. Nurse & Allied gross margin rose to 25.1%, up 240 bps from last year and 350 bps sequentially, as the mix shifted toward urgent placements, though management cautioned that this benefit will fade as event volume normalizes.

Technology and AI Power Faster Recruiter Productivity

AMN highlighted accelerating adoption of its WorkWise platform and AI tools, noting that its AI recruiter was involved in deploying more than 10,000 clinicians during the quarter. Usage of the AMN Passport app increased more than 30% year over year, with monthly active users up over 50%, while new AI‑driven WorkWise features aim to shorten hiring cycles and improve candidate matching.

International and Search Businesses Turn a Corner

International staffing returned to year‑over‑year growth, with management citing roughly 17% quarter‑over‑quarter improvement as a sign of early recovery despite regulatory and visa‑related friction. The leadership search business, including permanent physician placement and executive searches, also returned to year‑over‑year revenue growth, suggesting stabilization in longer‑cycle recruitment demand.

Operational Discipline Tightens DSO and Strengthens Client Ties

Days sales outstanding were reported at 26 days, though excluding working capital effects from the large disruptions, underlying DSO was 54 days, four days better than a year ago and two days lower sequentially. Management also pointed to deepened client relationships formed during crisis staffing events, with renewed and expanded contracts from major locum customers as hospitals reward AMN’s support during disruptions.

Heavy Reliance on Event Revenue Raises Sustainability Questions

Roughly half of Q1 revenue, or $722 million, came from labor disruption events that carry elevated bill rates and margins but are inherently unpredictable. Executives stressed that these unique conditions will not fully repeat in coming quarters, and investors should view the quarter as a test of AMN’s surge capacity rather than a new run‑rate baseline for revenue and profitability.

Segment Declines Highlight Areas of Weakness

Not all businesses participated in the upside, as Physician & Leadership Solutions revenue fell 6% year over year, with locum tenens down around 7%–9% and interim leadership down roughly 4%. Technology & Workforce Solutions revenue slid 15% year over year, or about 10% excluding a divestiture, though management noted the trajectory as an improvement compared with prior sequential declines.

Margin Pressure Persists in Technology and Physician Lines

Despite sequential improvement, consolidated gross margin was still 190 bps lower than a year ago, reflecting structural pressure in certain businesses outside the event windfall. Technology & Workforce Solutions gross margin dropped 550 bps year over year, and Physician & Leadership Solutions margins shrank by 120 bps, weighed down by lower locum profitability and higher sales reserves that shaved about 110 bps from segment margins.

Event‑Driven Costs Inflate SG&A

Adjusted SG&A expenses rose to $205 million, with reported SG&A at $218 million, driven by more than $70 million of costs tied to the large labor disruption engagements. Management portrayed these elevated costs as largely episodic and linked to the complexity and intensity of supporting multiple large‑scale disruptions concurrently.

Locums and Third‑Party Channel Face Competitive Strain

Locum tenens demand was described as softer overall, with a growing share of volume in more crowded third‑party channels where fill rates are harder to maintain and pricing is tighter. AMN expects Physician & Leadership Solutions revenue to decline about 6%–8% year over year in the second quarter, suggesting continued pressure as the firm navigates a more competitive marketplace.

Language Services Hit by Pricing and Volume Headwinds

Language services revenue slipped to $69 million, an 8% year‑over‑year decline driven by pricing pressure and fewer billed minutes as clients scrutinize spend and alternative solutions. While margins improved by roughly 200 bps sequentially after a new service model rollout, management signaled that pricing remains aggressive and that any stabilization will likely be gradual rather than immediate.

Cash Composition Skews Toward Client Deposits

A large portion of AMN’s reported cash balance reflects client deposits associated with labor disruption projects, which reached $367 million at quarter end with about $250 million refunded shortly thereafter. Management estimated that after remaining refunds, pro forma cash would fall to around $175 million, highlighting a forthcoming normalization in liquidity as these temporary deposits unwind.

International Growth Clouded by Visa Processing Uncertainty

While international demand is recovering, AMN cautioned that embassy processing bottlenecks and evolving policy conditions limit visibility into the pace of growth. The company is not modeling a rapid acceleration in international placements near term and framed potential upside through late 2026 and 2027 as contingent on improved visa throughput and regulatory clarity.

Guidance Signals a Sharper Slowdown After Exceptional Quarter

For the second quarter, AMN guided consolidated revenue to $620 million–$635 million, with only about $10 million of labor disruption revenue included, implying a significant step down from Q1’s event‑driven peak. The company expects gross margin between 28.0% and 28.5%, adjusted EBITDA margin of 6.7%–7.2%, and segment revenues ranging from flat to modestly down in Nurse & Allied, down 6%–8% in Physician & Leadership, and down 14%–16% in Technology & Workforce Solutions, consistent with a more normalized environment and conservative posture.

AMN Healthcare’s earnings call painted the picture of a company that executed exceptionally well during an extraordinary quarter but faces a more challenging and less predictable road as event work recedes. Investors are left weighing the strength of the core Nurse & Allied recovery, the benefits of technology and AI investments, and a solid balance sheet against ongoing margin pressure, competitive intensification, and near‑term revenue headwinds signaled in the guidance.